These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3147810)

  • 21. Effect of the sulfonylurea glyburide on glycogen synthesis in alloxan-induced diabetic rat hepatocytes.
    Atalay T; Altan N; Ongun CO; Alagöl H
    Gen Pharmacol; 1994 Nov; 25(7):1435-7. PubMed ID: 7896057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic cardiomyopathy in rats: mechanical and biochemical response to different insulin doses.
    Fein FS; Malhotra A; Miller-Green B; Scheuer J; Sonnenblick EH
    Am J Physiol; 1984 Nov; 247(5 Pt 2):H817-23. PubMed ID: 6238541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
    Khandekar S; Sethi BK; Dash RJ
    J Assoc Physicians India; 1990 Jul; 38(7):469-71. PubMed ID: 2127273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac myosin isoenzyme shifts in non-insulin treated spontaneously diabetic rats.
    Baum VC; Clark WA; Pelligrino DA
    Diabetes Res; 1989 Apr; 10(4):187-90. PubMed ID: 2533019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of glyburide on myocardial metabolism and function.
    Schaffer SW; Tan BH; Mozaffari MS
    Am J Med; 1985 Sep; 79(3B):48-52. PubMed ID: 3931461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of glyburide on metabolic control and insulin binding in insulin-dependent diabetes mellitus.
    Goldman J; Tamayo RC; Whitehouse FW; Kahkonen DM
    Diabetes Care; 1984; 7 Suppl 1():106-12. PubMed ID: 6428843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits.
    Nieszner E; Posa I; Kocsis E; Pogátsa G; Préda I; Koltai MZ
    Exp Clin Endocrinol Diabetes; 2002 Aug; 110(5):212-8. PubMed ID: 12148084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination insulin-sulfonylurea therapy.
    Lebovitz HE; Pasmantier R
    Diabetes Care; 1990 Jun; 13(6):667-75. PubMed ID: 2192850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tolbutamide on myocardial metabolism and mechanical performance of the diabetic rat.
    Tan BH; Wilson GL; Schaffer SW
    Diabetes; 1984 Dec; 33(12):1138-43. PubMed ID: 6500190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.
    DeFronzo RA; Simonson DC
    Diabetes Care; 1984; 7 Suppl 1():72-80. PubMed ID: 6428844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of insulin and sulfonylurea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients.
    Rivellese AA; Patti L; Romano G; Innelli F; Di Marino L; Annuzzi G; Iavicoli M; Coronel GA; Riccardi G
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4188-92. PubMed ID: 11095452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Acacia nilotica leaves extract on hyperglycaemia, lipid profile and platelet aggregation in streptozotocin induced diabetic rats.
    Asad M; Aslam M; Munir TA; Nadeem A
    J Ayub Med Coll Abbottabad; 2011; 23(2):3-7. PubMed ID: 24800330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the sulfonylurea glyburide on glutathione and glutathione peroxidase activity in alloxan-induced diabetic rat hepatocytes.
    Altan N; Ongun CO; Elmali E; Kiliç N; Yavuz O; Cayci B
    Gen Pharmacol; 1994 Sep; 25(5):875-8. PubMed ID: 7835630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Behavior of lactate and pyruvate in diabetics treated with a combination of fenformin and sulfonylurea in varying doses. I].
    Lunetta M; Presti C; Mughini MT; Mughini L
    Clin Ter; 1980 Jun; 93(5):525-33. PubMed ID: 6775863
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin reversal of biochemical changes in hearts from diabetic rats.
    Bhimji S; Godin DV; McNeill JH
    Am J Physiol; 1986 Sep; 251(3 Pt 2):H670-5. PubMed ID: 2944395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
    [No Abstract]   [Full Text] [Related]  

  • 37. [The importance of serum insulin determination in the diagnosis and treatment of diabetes mellitus (author's transl)].
    Willms B
    MMW Munch Med Wochenschr; 1975 Oct; 117(41):1643-8. PubMed ID: 810689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
    Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
    Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
    Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M
    Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiating effects of combined usage of three sulfonylurea drugs on the occurrence of alloxan diabetes in rats.
    Katsumata K; Katsumata Y; Ozawa T; Katsumata K
    Horm Metab Res; 1993 Feb; 25(2):125-6. PubMed ID: 8458609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.